Apellis Reports Top-Line Results from Phase III Studies Evaluating Pegcetacoplan for Geographic Atrophy September 17, 2021 Auto Bot News 0 Apellis Pharmaceuticals has announced the top-line results from two Phase III studies, evaluating intravitreal pegcetacoplan as a treatment for geographic atrophy.